GlassScriptPhysician profile
David William Dexter
NPI 1770585655
$10,840.27
in general payments reported to CMS, 2019-2025
31 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,223 · 2022: $638 · 2023: $5,658 · 2024: $477 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,638 · Honoraria: $2,250 · Travel and Lodging: $1,921 · Education: $1,000 · Gift: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,638.40 |
| Honoraria | $2,250.00 |
| Travel and Lodging | $1,921.38 |
| Education | $1,000.00 |
| Gift | $169.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,475.15 | 2021-2025 | Da Vinci Surgical System, Davinci Xi |
| Davol INC. | $2,669.90 | 2021-2025 | Phasix Mesh |
| Smith+Nephew, INC. | $402.92 | 2021-2025 | Collagenase Santyl, Stravix, Grafix |
| Imperative Care, INC | $328.00 | 2025 | Symphony Catheter |
| Medtronic, INC. | $257.49 | 2025 | Closurefast, Ligasure, Transorb |
| Mimedx Group, INC. | $242.63 | 2025 | |
| Stryker Corporation | $215.63 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Molli |
| Baxter Healthcare | $122.85 | 2024-2025 | Perclot, Tisseel |
| Conmed Corporation | $118.89 | 2023-2025 | Airseal, Visiclear |
| Inari Medical, INC. | $116.67 | 2021 | |
| Tela Bio, INC. | $114.76 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polymedics Innovations INC. | $92.91 | 2025 | |
| Ethicon US, LLC | $85.39 | 2022-2025 | Echelon Endopath, Echelon Circular, Stratafix |
| Dilon Technologies, INC. | $84.67 | 2023 | Hemoblast Bellows |
| Innovation Technologies INC | $74.17 | 2021-2024 | Irrisept |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $72.39 | 2025 | |
| Merit Medical Systems INC | $39.15 | 2023 | Savi Scout |
| Becton, Dickinson and Company | $36.43 | 2022 | |
| Kci USA, INC. | $34.80 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $33.49 | 2022-2024 | Exparel |
| Distalmotion US | $25.70 | 2025 | Dexter L6 Robot |
| Organogenesis INC. | $25.07 | 2022 | |
| Allergan, INC. | $24.99 | 2021 | |
| Abbott Laboratories | $22.65 | 2024 | Proclaim |
| Biocomposites INC | $21.40 | 2025 | Stimulan |
| Reapplix INC. | $20.31 | 2025 | 3c Patch Kit - Box |
| Kerecis Limited | $19.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Molnlycke Health Care US, LLC | $16.68 | 2024 | Mepilex Border Post-Op |
| Solventum Corporation | $15.52 | 2025 | Prevena, V.A.C.Instill |
| Hartmann USA, INC. | $15.45 | 2025 | Zetuvit Plus 10x10 P10 |
| Heron Therapeutics, INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dexter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.